Executive Chairman and President of Botanix, Vince Ippolito, commented: “........
“It was apparent that outside GW Pharmaceuticals’ FDA approved Epidiolex epilepsy product, Botanix
has the most mature development pipeline of any other cannabinoid company featured at the iCDP
Summit. Our rapid development approach has distinguished us from our peers, many of whom have
been in development for 5 to 15 years and are only now starting human studies for the first time.”
- Forums
- ASX - By Stock
- BOT
- Ann: Botanix Presents at International Cannabinoid Summit
Ann: Botanix Presents at International Cannabinoid Summit, page-2
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.8¢ |
Change
0.008(3.57%) |
Mkt cap ! $346.5M |
Open | High | Low | Value | Volume |
21.5¢ | 22.0¢ | 21.3¢ | $590.9K | 2.720M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 992110 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 365651 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 992110 | 0.215 |
26 | 1108521 | 0.210 |
17 | 604053 | 0.205 |
28 | 1609832 | 0.200 |
17 | 686689 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 365651 | 4 |
0.225 | 1295176 | 9 |
0.230 | 419541 | 11 |
0.235 | 598123 | 11 |
0.240 | 878759 | 16 |
Last trade - 15.31pm 29/04/2024 (20 minute delay) ? |
|
|||||
Last
22.0¢ |
  |
Change
0.008 ( 1.24 %) |
|||
Open | High | Low | Volume | ||
21.5¢ | 22.0¢ | 21.3¢ | 1453353 | ||
Last updated 15.40pm 29/04/2024 ? |
Featured News
BOT (ASX) Chart |